Pharmaceutical Care Strategies for Stroke Patients: A Comprehensive Review
Published: 2023-10-11
Page: 370-375
Issue: 2023 - Volume 6 [Issue 1]
Sainath Chary Gannoji *
St. Paul’s College of Pharmacy, Hyderabad, Telangana, India.
Soujanya Durishetty
St. Paul’s College of Pharmacy, Hyderabad, Telangana, India.
Raheemunnissa
St. Paul’s College of Pharmacy, Hyderabad, Telangana, India.
Vedavathi Sai G.
East West College of Pharmacy, Bangalore, Karnataka, India.
Shivankitha Kattekola
Sri Venkateshwara College of Pharmacy, Hyderabad, Telangana, India.
Purbai Dheeraj
Malla Reddy Pharmacy College, Hyderabad, Telangana, India.
Parsi Lavanya
St. Paul’s College of Pharmacy, Hyderabad, Telangana, India.
*Author to whom correspondence should be addressed.
Abstract
Stroke is a clinical syndrome characterized by rapidly developing clinical symptoms of focal (or global, in the case of coma) brain dysfunction lasting more than 24 hours or causing death with no apparent cause other than vascular. Stroke is broadly divided into subarachnoid hemorrhage, ischemic stroke, and hemorrhagic stroke. Stroke is the second leading cause of death and the third leading cause of disability worldwide. Stroke is the most common non-communicable disease (NCD) in India, accounting for 3.5 percent of Disability-Adjusted Life Years (DALY). According to studies, the prevalence of strokes in India is 116-163 strokes per 100,000 people. Recently, the ICMR published a report titled "India: According to the National Health Service, stroke was the fourth leading cause of death and the fifth leading cause of Disability-Adjusted Life Years (DALYs) in 2016". All the literature evaluating pharmacy interventions in stroke patients and the role of the clinical pharmacist in the evidence supporting stroke care are well established. This review aims to provide a comprehensive explanation of pharmacist interventions for stroke patients. Outcomes can be improved by clinical pharmacist involvement in the prescribing process, computerized entry of medication orders, pre-administration monitoring of drug interactions, and patient counseling.
Keywords: Stroke, clinical pharmacists, pharmaceutical care plan, drug related problems
How to Cite
Downloads
References
Hatano S. Experience from a multicentre stroke register: a preliminary report. Bulletin of the World Health Organisation. 1976;54((5):):541-553.. [PMC free article] [PubMed] [Google Scholar]
Caplan LR. Caplan's Stroke: A Clinical Approach, 4th ed, Saunders Elsevier, Philadelphia:. Basic pathology, anatomy, and pathophysiology of stroke. 2009;22. [Google Scholar]
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095.. [PubMed] [Google Scholar]
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of first-ever ischaemic and hemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259. [PMC free article] [PubMed] [Google Scholar]
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135:e146. [PMC free article] [PubMed] [Google Scholar]
Adams HP, Jr,, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999; 13;53(1):126––131.. [PubMed] [Google Scholar]
Scott JS, Sampson EF, D’Amato T. Self-medication in hospitalized stroke patients: effectiveness of medication counselling for right and left hemiplegics [abstract]. Presented at the Annual Meeting of the American Society of Health-System Pharmacists; 1989:32E.
Jackson SL, Peterson GM. Stroke risk assessment for atrial fibrillation: Hospital-based stroke risk assessment and intervention program. J. Clin. Pharm. Ther. 2011;36:71–79. [Google Scholar] [CrossRef] [PubMed]
del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945- 2948.
Adams HP Jr, del Zoppo G, Alberts MJ. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
Activase (alteplase) package insert. South San Francisco, CA: Genentech, Inc; April 2011.
Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A Pharmacist-Led Multidisciplinary Intervention. J. Am. Geriatr. Soc. 2005;53:1912–1920.
[Google Scholar] [CrossRef] [PubMed]
Virdee MS, Stewart D. Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: A pharmacist-led intervention. Int. J. Clin. Pharm. 2017;39: 173–180. [Google Scholar] [CrossRef]
Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for Atrial Fibrillation in Older People: A Pharmacist-Led Multidisciplinary Intervention. J. Am. Geriatr. Soc. 2005;53:1912–1920.
[Google Scholar] [CrossRef] [PubMed]
Jackson SL, Peterson GM. Stroke risk assessment for atrial fibrillation: Hospital-based stroke risk assessment and intervention program. J. Clin. Pharm. Ther. 2011;36:71–79. [Google Scholar] [CrossRef] [PubMed]
Carina Hohmann, Tobias Neumann-Haefelin , Ju¨rgen M. Klotz, Annette Freidank, Roland RadziwillInt J; Drug-related problems in patients with ischemic stroke in hospital Clin Pharm. 2012; 34:828–831. DOI 10.1007/s11096-012-9690-7
Kannikar Semcharoen, Sajja Supornpun, Surakit Nathi suwan, Junporn Kongwat charapong et al.., Characteristic of drug related problems and pharmacists’ interventions in a stroke unit in Thailand, International Journal of Clinical Pharmacy (2019), https://doi.org/10.1007/s11096-019-00832-4.
Celin A.T, Seuma J, Ramesh A* Assessment of drug related problems in stroke patients admitted to a South Indian Tertiary care teaching hospital. Indian Journal of Pharmacy Practice .2012;5(4).